1 Introduction People with diabetes show heterogeneity in cardiovascular disease (CVD) risk [1-3]. Several promising blood-based biomarkers have shown predictive value for CVD risk in patients with diabetes, including high sensitivity C-reactive protein (hs-CRP) [4], N terminal pro-B-type natriuretic peptide (NT-proBNP) [5-7], and high sensitivity troponins (hs-cTNT and hs-cTnI) [8, 9].
William MacDonald
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with William
Contact William, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack